As of the most recent data, ECTE shows a P/B ratio of 0.0. That is below the sector sector average of 4.66. Scroll down for historical charts and peer comparison views.

The its sector sector average P/B ratio is about 4.66. Echo Therapeutics is at 0.0, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how ECTE stacks up against individual peers as well.

Investors watch ECTE's P/B ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Echo Therapeutics's latest reading is 0.0. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this price-to-book ratio page, Stockcircle has Echo Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/B ratio (currently 0.0) with ownership activity and broader fundamentals.